Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C23H29NO3 |
| Molecular Weight | 367.4813 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)C1(CCN(CCC(O)C2=CC=CC=C2)CC1)C3=CC=CC=C3
InChI
InChIKey=IPOPQVVNCFQFRK-UHFFFAOYSA-N
InChI=1S/C23H29NO3/c1-2-27-22(26)23(20-11-7-4-8-12-20)14-17-24(18-15-23)16-13-21(25)19-9-5-3-6-10-19/h3-12,21,25H,2,13-18H2,1H3
| Molecular Formula | C23H29NO3 |
| Molecular Weight | 367.4813 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
PHENOPERIDINE is an opioid analgesic partly metabolized to meperidine in the liver. It is derived from pethidine by replacing the N methyl by a phenyl propanol chain. It is reputed to be a typical morphine-like analgesic characterized by its high potency, rapid onset of action, the intensity of its peak effect and the short duration of its pharmacological effects. It is used in general anesthesia.
Originator
Approval Year
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
1330 ng × min/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/4027103/ |
2 mg single, intravenous dose: 2 mg route of administration: Intravenous experiment type: SINGLE co-administered: |
PHENOPERIDINE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
193 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/4027103/ |
2 mg single, intravenous dose: 2 mg route of administration: Intravenous experiment type: SINGLE co-administered: |
PHENOPERIDINE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
Funbound
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
21.17% |
15 μg/kg bw single, intravenous dose: 15 μg/kg bw route of administration: Intravenous experiment type: SINGLE co-administered: |
PHENOPERIDINE plasma | Homo sapiens population: UNKNOWN age: UNKNOWN sex: UNKNOWN food status: UNKNOWN |
PubMed
| Title | Date | PubMed |
|---|---|---|
| The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice. | 2009-04-29 |
|
| Contemporary strategies to preserve renal function during cardiac and vascular surgery. | 2003 |
|
| Motor neuropathy associated with cimetidine. | 1980-10-11 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:28:13 GMT 2025
by
admin
on
Wed Apr 02 08:28:13 GMT 2025
|
| Record UNII |
G9BH09J4JW
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
N01AH04
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
||
|
WHO-VATC |
QN01AH04
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
||
|
NCI_THESAURUS |
C1506
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
||
|
NCI_THESAURUS |
C241
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
||
|
DEA NO. |
9641
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C72123
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
PRIMARY | |||
|
DB13605
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
PRIMARY | |||
|
100000082259
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105385
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
PRIMARY | |||
|
DTXSID90862199
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
PRIMARY | |||
|
209-229-2
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
PRIMARY | |||
|
8143
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
PRIMARY | RxNorm | ||
|
D010638
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
PRIMARY | |||
|
G9BH09J4JW
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
PRIMARY | |||
|
562-26-5
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
PRIMARY | |||
|
11226
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
PRIMARY | |||
|
PHENOPERIDINE
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
PRIMARY | |||
|
1062
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
PRIMARY | |||
|
m8632
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
PRIMARY | Merck Index | ||
|
3441
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
PRIMARY | |||
|
SUB09775MIG
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
PRIMARY | |||
|
66584-15-4
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
SUPERSEDED | |||
|
55125-88-7
Created by
admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
|
SUPERSEDED |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |